Citation: G. Ragnarsson et G. Bodemar, Treatment of irritable bowel syndrome with loperamide oxide. An open studyto determine optimal dosage, J INTERN M, 248(2), 2000, pp. 165-166
Authors:
Sigbjornsdottir, BI
Ragnarsson, G
Agnarsson, BA
Chen, HP
Barkardottir, RB
Egilsson, V
Ingvarsson, S
Citation: Bi. Sigbjornsdottir et al., Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer, J MED GENET, 37(5), 2000, pp. 342-347
Citation: G. Ragnarsson, Opposition to the Icelandic database is based on false information (vol 318, pg 1354, 1999), BR MED J, 319(7202), 1999, pp. 90-90
Authors:
Johannsdottir, JT
Bergthorsson, JT
Gretarsdottir, S
Kristjansson, AK
Ragnarsson, G
Jonasson, JG
Egilsson, V
Ingvarsson, S
Citation: Jt. Johannsdottir et al., Replication error in colorectal carcinoma: Association with loss of heterozygosity at mismatch repair loci and clinicopathological variables, ANTICANC R, 19(3A), 1999, pp. 1821-1826
Citation: G. Ragnarsson et al., Abdominal symptoms are not related to anorectal function in the irritable bowel syndrome, SC J GASTR, 34(3), 1999, pp. 250-258
Citation: G. Ragnarsson et G. Bodemar, Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatient samples, SC J GASTR, 34(10), 1999, pp. 993-1000
Authors:
Ragnarsson, G
Eiriksdottir, G
Johannsdottir, JT
Jonasson, JG
Egilsson, V
Ingvarsson, S
Citation: G. Ragnarsson et al., Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival, BR J CANC, 79(9-10), 1999, pp. 1468-1474